Event Date: The earnings call was conducted on August 06, 2026
Purpose: Discussion of Q1 FY27 financial results
Regulatory Basis: Filed pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Management Participants: Not specified in this disclosure
Recording Availability: Audio and video recordings of the earnings call are available at https://www.biocon.com/investor-relations/financial-information/quarterly-reports/fy-2026-27/
Additional Availability: Recordings are also available on the company website at www.biocon.com
UPSI Statement: The disclosure does not contain any statement regarding unpublished price sensitive information
Additional Notes Section
Financial Data Disclosure: This regulatory filing does not contain any financial figures, results, or guidance from Q1 FY27
Attachments: No attachments were mentioned in this specific disclosure
Compliance Officer: The filing was digitally signed by Rajesh U. Shanoy, Company Secretary and Compliance Officer (ICSI Membership Number: A16328)
